Wang Yigang, Liu Hui-Hui, Cao Yu-Ting, Zhang Lei-Lei, Huang Fang, Yi Cong
Xinyuan Institute of Medicine and Biotechnology, School of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Front Cell Dev Biol. 2020 Jun 10;8:413. doi: 10.3389/fcell.2020.00413. eCollection 2020.
Mitochondria are key cellular organelles and play vital roles in energy metabolism, apoptosis regulation and cellular homeostasis. Mitochondrial dynamics refers to the varying balance between mitochondrial fission and mitochondrial fusion that plays an important part in maintaining mitochondrial homeostasis and quality. Mitochondrial malfunction is involved in aging, metabolic disease, neurodegenerative disorders, and cancers. Mitophagy, a selective autophagy of mitochondria, can efficiently degrade, remove and recycle the malfunctioning or damaged mitochondria, and is crucial for quality control. In past decades, numerous studies have identified a series of factors that regulate mitophagy and are also involved in carcinogenesis, cancer cell migration and death. Therefore, it has become critically important to analyze signal pathways that regulate mitophagy to identify potential therapeutic targets. Here, we review recent progresses in mitochondrial dynamics, the mechanisms of mitophagy regulation, and the implications for understanding carcinogenesis, metastasis, treatment, and drug resistance.
线粒体是关键的细胞器,在能量代谢、细胞凋亡调控和细胞内稳态中发挥着至关重要的作用。线粒体动力学是指线粒体裂变和线粒体融合之间不断变化的平衡,这对维持线粒体稳态和质量起着重要作用。线粒体功能障碍与衰老、代谢性疾病、神经退行性疾病和癌症有关。线粒体自噬是一种选择性的线粒体自噬,能够有效降解、清除和循环利用功能失调或受损的线粒体,对质量控制至关重要。在过去几十年中,大量研究已经确定了一系列调节线粒体自噬的因素,这些因素也参与了肿瘤发生、癌细胞迁移和死亡。因此,分析调节线粒体自噬的信号通路以确定潜在的治疗靶点变得至关重要。在此,我们综述了线粒体动力学、线粒体自噬调控机制以及对理解肿瘤发生、转移、治疗和耐药性的意义方面的最新进展。
Front Cell Dev Biol. 2020-6-10
Oxid Med Cell Longev. 2019-11-4
Sheng Li Xue Bao. 2020-8-25
Redox Biol. 2015
Biochem Biophys Res Commun. 2017-1-15
Biochim Biophys Acta. 2015-10
Adv Exp Med Biol. 2019
Oxid Med Cell Longev. 2022
Curr Pharm Des. 2014
Cancers (Basel). 2025-8-14
Int J Mol Sci. 2025-7-24
World J Surg Oncol. 2025-6-9
Front Pharmacol. 2025-4-1
Cell Mol Biol Lett. 2025-4-7
BMC Cancer. 2025-3-6
Int J Biol Sci. 2025-1-27
Annu Rev Pathol. 2019-10-4
Cancer Res. 2019-9-5
Semin Cancer Biol. 2020-11
Cancer Discov. 2019-7-1
Nat Immunol. 2019-2-25